カテゴリー： LP Information, 世界, 部品/材料

世界のカルバペネムAPI市場予測 2021年-2026年

【英語タイトル】Global Carbapenem API Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY0916）・商品コード：LPI21MY0916
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：166
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「カルバペネムAPIの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、エルタペネムAPI、イミペネムAPI、メロペネムAPI、その他など、用途別には、静脈注射、筋肉内注射などにセグメント区分してまとめました。カルバペネムAPIのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・カルバペネムAPIの世界市場概要（サマリー）
・カルバペネムAPIの企業別販売量・売上
・カルバペネムAPIの企業別市場シェア
・カルバペネムAPIの世界市場規模 2016年-2021年：種類別（エルタペネムAPI、イミペネムAPI、メロペネムAPI、その他）
・カルバペネムAPIの世界市場規模 2016年-2021年：用途別（静脈注射、筋肉内注射）
・カルバペネムAPIの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・カルバペネムAPIのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・カルバペネムAPIのヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・カルバペネムAPIの中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・カルバペネムAPI市場の成長要因・課題・動向
・カルバペネムAPIの世界市場予測 2021年-2026年
・カルバペネムAPIの南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・カルバペネムAPIのアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・カルバペネムAPIのヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・カルバペネムAPIの中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・カルバペネムAPIの世界市場予測：種類別（エルタペネムAPI、イミペネムAPI、メロペネムAPI、その他）
・カルバペネムAPIの世界市場予測：用途別（静脈注射、筋肉内注射）
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Carbapenem API will have significant change from previous year. By the most conservative estimates of global Carbapenem API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Carbapenem API market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Carbapenem API market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Ertapenem API
Imipenem API
Meropenem API
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Intravenous Injection
Intramuscular Injection

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
ACS Dobfar
Savior Lifetec Corporation
Sumitomo Chemical Company
Shenzhen Haibin Pharmaceutical
Zhuhai United Laboratories
Zhejiang Hisun Pharmaceutical
Zhejiang Jiuzhou Pharmaceutical
Sun Pharma
Kopran
Hainan Haiyao
Zhejiang Hisoar
Kaliberr Labs
Jeil Pharmaceutical
Qilu Pharmaceutical

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Carbapenem API Consumption 2016-2026
2.1.2 Carbapenem API Consumption CAGR by Region
2.2 Carbapenem API Segment by Type
2.2.1 Ertapenem API
2.2.2 Imipenem API
2.2.3 Meropenem API
2.2.4 Others
2.3 Carbapenem API Sales by Type
2.3.1 Global Carbapenem API Sales Market Share by Type (2016-2021)
2.3.2 Global Carbapenem API Revenue and Market Share by Type (2016-2021)
2.3.3 Global Carbapenem API Sale Price by Type (2016-2021)
2.4 Carbapenem API Segment by Application
2.4.1 Intravenous Injection
2.4.2 Intramuscular Injection
2.5 Carbapenem API Sales by Application
2.5.1 Global Carbapenem API Sale Market Share by Application (2016-2021)
2.5.2 Global Carbapenem API Revenue and Market Share by Application (2016-2021)
2.5.3 Global Carbapenem API Sale Price by Application (2016-2021)

3 Global Carbapenem API by Company
3.1 Global Carbapenem API Sales Market Share by Company
3.1.1 Global Carbapenem API Sales by Company (2019-2021)
3.1.2 Global Carbapenem API Sales Market Share by Company (2019-2021)
3.2 Global Carbapenem API Revenue Market Share by Company
3.2.1 Global Carbapenem API Revenue by Company (2019-2021)
3.2.2 Global Carbapenem API Revenue Market Share by Company (2019-2021)
3.3 Global Carbapenem API Sale Price by Company
3.4 Global Manufacturers Carbapenem API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Carbapenem API Product Location Distribution
3.4.2 Players Carbapenem API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Carbapenem API by Region
4.1 Global Carbapenem API by Region
4.1.1 Global Carbapenem API Sales by Region
4.1.2 Global Carbapenem API Revenue by Region
4.2 Americas Carbapenem API Sales Growth
4.3 APAC Carbapenem API Sales Growth
4.4 Europe Carbapenem API Sales Growth
4.5 Middle East & Africa Carbapenem API Sales Growth

5 Americas
5.1 Americas Carbapenem API Sales by Country
5.1.1 Americas Carbapenem API Sales by Country (2016-2021)
5.1.2 Americas Carbapenem API Revenue by Country (2016-2021)
5.2 Americas Carbapenem API Sales by Type
5.3 Americas Carbapenem API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Carbapenem API Sales by Region
6.1.1 APAC Carbapenem API Sales by Region (2016-2021)
6.1.2 APAC Carbapenem API Revenue by Region (2016-2021)
6.2 APAC Carbapenem API Sales by Type
6.3 APAC Carbapenem API Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Carbapenem API by Country
7.1.1 Europe Carbapenem API Sales by Country (2016-2021)
7.1.2 Europe Carbapenem API Revenue by Country (2016-2021)
7.2 Europe Carbapenem API Sales by Type
7.3 Europe Carbapenem API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Carbapenem API by Country
8.1.1 Middle East & Africa Carbapenem API Sales by Country (2016-2021)
8.1.2 Middle East & Africa Carbapenem API Revenue by Country (2016-2021)
8.2 Middle East & Africa Carbapenem API Sales by Type
8.3 Middle East & Africa Carbapenem API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Carbapenem API Distributors
10.3 Carbapenem API Customer

11 Global Carbapenem API Market Forecast
11.1 Global Carbapenem API Forecast by Region
11.1.1 Global Carbapenem API Forecast by Regions (2021-2026)
11.2.2 Global Carbapenem API Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Carbapenem API Forecast by Type
11.7 Global Carbapenem API Forecast by Application

12 Key Players Analysis
12.1 ACS Dobfar
12.1.1 ACS Dobfar Company Information
12.1.2 ACS Dobfar Carbapenem API Product Offered
12.1.3 ACS Dobfar Carbapenem API Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 ACS Dobfar Main Business Overview
12.1.5 ACS Dobfar Latest Developments
12.2 Savior Lifetec Corporation
12.2.1 Savior Lifetec Corporation Company Information
12.2.2 Savior Lifetec Corporation Carbapenem API Product Offered
12.2.3 Savior Lifetec Corporation Carbapenem API Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Savior Lifetec Corporation Main Business Overview
12.2.5 Savior Lifetec Corporation Latest Developments
12.3 Sumitomo Chemical Company
12.3.1 Sumitomo Chemical Company Company Information
12.3.2 Sumitomo Chemical Company Carbapenem API Product Offered
12.3.3 Sumitomo Chemical Company Carbapenem API Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Sumitomo Chemical Company Main Business Overview
12.3.5 Sumitomo Chemical Company Latest Developments
12.4 Shenzhen Haibin Pharmaceutical
12.4.1 Shenzhen Haibin Pharmaceutical Company Information
12.4.2 Shenzhen Haibin Pharmaceutical Carbapenem API Product Offered
12.4.3 Shenzhen Haibin Pharmaceutical Carbapenem API Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Shenzhen Haibin Pharmaceutical Main Business Overview
12.4.5 Shenzhen Haibin Pharmaceutical Latest Developments
12.5 Zhuhai United Laboratories
12.5.1 Zhuhai United Laboratories Company Information
12.5.2 Zhuhai United Laboratories Carbapenem API Product Offered
12.5.3 Zhuhai United Laboratories Carbapenem API Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Zhuhai United Laboratories Main Business Overview
12.5.5 Zhuhai United Laboratories Latest Developments
12.6 Zhejiang Hisun Pharmaceutical
12.6.1 Zhejiang Hisun Pharmaceutical Company Information
12.6.2 Zhejiang Hisun Pharmaceutical Carbapenem API Product Offered
12.6.3 Zhejiang Hisun Pharmaceutical Carbapenem API Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Zhejiang Hisun Pharmaceutical Main Business Overview
12.6.5 Zhejiang Hisun Pharmaceutical Latest Developments
12.7 Zhejiang Jiuzhou Pharmaceutical
12.7.1 Zhejiang Jiuzhou Pharmaceutical Company Information
12.7.2 Zhejiang Jiuzhou Pharmaceutical Carbapenem API Product Offered
12.7.3 Zhejiang Jiuzhou Pharmaceutical Carbapenem API Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Zhejiang Jiuzhou Pharmaceutical Main Business Overview
12.7.5 Zhejiang Jiuzhou Pharmaceutical Latest Developments
12.8 Sun Pharma
12.8.1 Sun Pharma Company Information
12.8.2 Sun Pharma Carbapenem API Product Offered
12.8.3 Sun Pharma Carbapenem API Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Sun Pharma Main Business Overview
12.8.5 Sun Pharma Latest Developments
12.9 Kopran
12.9.1 Kopran Company Information
12.9.2 Kopran Carbapenem API Product Offered
12.9.3 Kopran Carbapenem API Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Kopran Main Business Overview
12.9.5 Kopran Latest Developments
12.10 Hainan Haiyao
12.10.1 Hainan Haiyao Company Information
12.10.2 Hainan Haiyao Carbapenem API Product Offered
12.10.3 Hainan Haiyao Carbapenem API Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Hainan Haiyao Main Business Overview
12.10.5 Hainan Haiyao Latest Developments
12.11 Zhejiang Hisoar
12.11.1 Zhejiang Hisoar Company Information
12.11.2 Zhejiang Hisoar Carbapenem API Product Offered
12.11.3 Zhejiang Hisoar Carbapenem API Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Zhejiang Hisoar Main Business Overview
12.11.5 Zhejiang Hisoar Latest Developments
12.12 Kaliberr Labs
12.12.1 Kaliberr Labs Company Information
12.12.2 Kaliberr Labs Carbapenem API Product Offered
12.12.3 Kaliberr Labs Carbapenem API Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Kaliberr Labs Main Business Overview
12.12.5 Kaliberr Labs Latest Developments
12.13 Jeil Pharmaceutical
12.13.1 Jeil Pharmaceutical Company Information
12.13.2 Jeil Pharmaceutical Carbapenem API Product Offered
12.13.3 Jeil Pharmaceutical Carbapenem API Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Jeil Pharmaceutical Main Business Overview
12.13.5 Jeil Pharmaceutical Latest Developments
12.14 Qilu Pharmaceutical
12.14.1 Qilu Pharmaceutical Company Information
12.14.2 Qilu Pharmaceutical Carbapenem API Product Offered
12.14.3 Qilu Pharmaceutical Carbapenem API Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Qilu Pharmaceutical Main Business Overview
12.14.5 Qilu Pharmaceutical Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Carbapenem API Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Ertapenem API
Table 3. Major Players of Imipenem API
Table 4. Major Players of Meropenem API
Table 5. Major Players of Others
Table 6. Global Carbapenem API Sales by Type (2016-2021) & (Ton)
Table 7. Global Carbapenem API Sales Market Share by Type (2016-2021)
Table 8. Global Carbapenem API Revenue by Type (2016-2021) & ($ million)
Table 9. Global Carbapenem API Revenue Market Share by Type (2016-2021)
Table 10. Global Carbapenem API Sale Price by Type (2016-2021)
Table 11. Global Carbapenem API Sales by Application (2016-2021) & (Ton)
Table 12. Global Carbapenem API Sales Market Share by Application (2016-2021)
Table 13. Global Carbapenem API Value by Application (2016-2021)
Table 14. Global Carbapenem API Revenue Market Share by Application (2016-2021)
Table 15. Global Carbapenem API Sale Price by Application (2016-2021)
Table 16. Global Carbapenem API Sales by Company (2019-2021) & (Ton)
Table 17. Global Carbapenem API Sales Market Share by Company (2019-2021)
Table 18. Global Carbapenem API Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Carbapenem API Revenue Market Share by Company (2019-2021)
Table 20. Global Carbapenem API Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Carbapenem API Producing Area Distribution and Sales Area
Table 22. Players Carbapenem API Products Offered
Table 23. Carbapenem API Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Carbapenem API Sales by Region (2016-2021) (Ton)
Table 27. Global Carbapenem API Sales Market Share by Region (2016-2021)
Table 28. Global Carbapenem API Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Carbapenem API Revenue Market Share by Region (2016-2021)
Table 30. Americas Carbapenem API Sales by Country (2016-2021) & (Ton)
Table 31. Americas Carbapenem API Sales Market Share by Country (2016-2021)
Table 32. Americas Carbapenem API Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Carbapenem API Revenue Market Share by Country (2016-2021)
Table 34. Americas Carbapenem API Sales by Type (2016-2021) & (Ton)
Table 35. Americas Carbapenem API Sales Market Share by Type (2016-2021)
Table 36. Americas Carbapenem API Sales by Application (2016-2021) & (Ton)
Table 37. Americas Carbapenem API Sales Market Share by Application (2016-2021)
Table 38. APAC Carbapenem API Sales by Region (2016-2021) & (Ton)
Table 39. APAC Carbapenem API Sales Market Share by Region (2016-2021)
Table 40. APAC Carbapenem API Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Carbapenem API Revenue Market Share by Region (2016-2021)
Table 42. APAC Carbapenem API Sales by Type (2016-2021) & (Ton)
Table 43. APAC Carbapenem API Sales Market Share by Type (2016-2021)
Table 44. APAC Carbapenem API Sales by Application (2016-2021) & (Ton)
Table 45. APAC Carbapenem API Sales Market Share by Application (2016-2021)
Table 46. Europe Carbapenem API Sales by Country (2016-2021) & (Ton)
Table 47. Europe Carbapenem API Sales Market Share by Country (2016-2021)
Table 48. Europe Carbapenem API Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Carbapenem API Revenue Market Share by Country (2016-2021)
Table 50. Europe Carbapenem API Sales by Type (2016-2021) & (Ton)
Table 51. Europe Carbapenem API Sales Market Share by Type (2016-2021)
Table 52. Europe Carbapenem API Sales by Application (2016-2021) & (Ton)
Table 53. Europe Carbapenem API Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Carbapenem API Sales by Country (2016-2021) & (Ton)
Table 55. Middle East & Africa Carbapenem API Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Carbapenem API Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Carbapenem API Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Carbapenem API Sales by Type (2016-2021) & (Ton)
Table 59. Middle East & Africa Carbapenem API Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Carbapenem API Sales by Application (2016-2021) & (Ton)
Table 61. Middle East & Africa Carbapenem API Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Carbapenem API
Table 63. Key Application and Potential Industries of Carbapenem API
Table 64. Key Challenges of Carbapenem API
Table 65. Key Trends of Carbapenem API
Table 66. Carbapenem API Distributors List
Table 67. Carbapenem API Customer List
Table 68. Global Carbapenem API Sales Forecast by Region (2021-2026) & (Ton)
Table 69. Global Carbapenem API Consumption Market Forecast by Region
Table 70. Global Carbapenem API Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Carbapenem API Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Carbapenem API Sales Forecast by Country (2021-2026) & (Ton)
Table 73. Americas Carbapenem API Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Carbapenem API Sales Forecast by Region (2021-2026) & (Ton)
Table 75. APAC Carbapenem API Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Carbapenem API Sales Forecast by Country (2021-2026) & (Ton)
Table 77. Europe Carbapenem API Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Carbapenem API Sales Forecast by Country (2021-2026) & (Ton)
Table 79. Middle East & Africa Carbapenem API Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Carbapenem API Sales Forecast by Type (2021-2026) & (Ton)
Table 81. Global Carbapenem API Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Carbapenem API Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Carbapenem API Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Carbapenem API Sales Forecast by Application (2021-2026) & (Ton)
Table 85. Global Carbapenem API Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Carbapenem API Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Carbapenem API Revenue Market Share Forecast by Application (2021-2026)
Table 88. ACS Dobfar Basic Information, Carbapenem API Manufacturing Base, Sales Area and Its Competitors
Table 89. ACS Dobfar Carbapenem API Product Offered
Table 90. ACS Dobfar Carbapenem API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 91. ACS Dobfar Main Business
Table 92. ACS Dobfar Latest Developments
Table 93. Savior Lifetec Corporation Basic Information, Carbapenem API Manufacturing Base, Sales Area and Its Competitors
Table 94. Savior Lifetec Corporation Carbapenem API Product Offered
Table 95. Savior Lifetec Corporation Carbapenem API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 96. Savior Lifetec Corporation Main Business
Table 97. Savior Lifetec Corporation Latest Developments
Table 98. Sumitomo Chemical Company Basic Information, Carbapenem API Manufacturing Base, Sales Area and Its Competitors
Table 99. Sumitomo Chemical Company Carbapenem API Product Offered
Table 100. Sumitomo Chemical Company Carbapenem API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 101. Sumitomo Chemical Company Main Business
Table 102. Sumitomo Chemical Company Latest Developments
Table 103. Shenzhen Haibin Pharmaceutical Basic Information, Carbapenem API Manufacturing Base, Sales Area and Its Competitors
Table 104. Shenzhen Haibin Pharmaceutical Carbapenem API Product Offered
Table 105. Shenzhen Haibin Pharmaceutical Carbapenem API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 106. Shenzhen Haibin Pharmaceutical Main Business
Table 107. Shenzhen Haibin Pharmaceutical Latest Developments
Table 108. Zhuhai United Laboratories Basic Information, Carbapenem API Manufacturing Base, Sales Area and Its Competitors
Table 109. Zhuhai United Laboratories Carbapenem API Product Offered
Table 110. Zhuhai United Laboratories Carbapenem API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 111. Zhuhai United Laboratories Main Business
Table 112. Zhuhai United Laboratories Latest Developments
Table 113. Zhejiang Hisun Pharmaceutical Basic Information, Carbapenem API Manufacturing Base, Sales Area and Its Competitors
Table 114. Zhejiang Hisun Pharmaceutical Carbapenem API Product Offered
Table 115. Zhejiang Hisun Pharmaceutical Carbapenem API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 116. Zhejiang Hisun Pharmaceutical Main Business
Table 117. Zhejiang Hisun Pharmaceutical Latest Developments
Table 118. Zhejiang Jiuzhou Pharmaceutical Basic Information, Carbapenem API Manufacturing Base, Sales Area and Its Competitors
Table 119. Zhejiang Jiuzhou Pharmaceutical Carbapenem API Product Offered
Table 120. Zhejiang Jiuzhou Pharmaceutical Carbapenem API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 121. Zhejiang Jiuzhou Pharmaceutical Main Business
Table 122. Zhejiang Jiuzhou Pharmaceutical Latest Developments
Table 123. Sun Pharma Basic Information, Carbapenem API Manufacturing Base, Sales Area and Its Competitors
Table 124. Sun Pharma Carbapenem API Product Offered
Table 125. Sun Pharma Carbapenem API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 126. Sun Pharma Main Business
Table 127. Sun Pharma Latest Developments
Table 128. Kopran Basic Information, Carbapenem API Manufacturing Base, Sales Area and Its Competitors
Table 129. Kopran Carbapenem API Product Offered
Table 130. Kopran Carbapenem API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 131. Kopran Main Business
Table 132. Kopran Latest Developments
Table 133. Hainan Haiyao Basic Information, Carbapenem API Manufacturing Base, Sales Area and Its Competitors
Table 134. Hainan Haiyao Carbapenem API Product Offered
Table 135. Hainan Haiyao Carbapenem API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 136. Hainan Haiyao Main Business
Table 137. Hainan Haiyao Latest Developments
Table 138. Zhejiang Hisoar Basic Information, Carbapenem API Manufacturing Base, Sales Area and Its Competitors
Table 139. Zhejiang Hisoar Carbapenem API Product Offered
Table 140. Zhejiang Hisoar Carbapenem API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 141. Zhejiang Hisoar Main Business
Table 142. Zhejiang Hisoar Latest Developments
Table 143. Kaliberr Labs Basic Information, Carbapenem API Manufacturing Base, Sales Area and Its Competitors
Table 144. Kaliberr Labs Carbapenem API Product Offered
Table 145. Kaliberr Labs Carbapenem API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 146. Kaliberr Labs Main Business
Table 147. Kaliberr Labs Latest Developments
Table 148. Jeil Pharmaceutical Basic Information, Carbapenem API Manufacturing Base, Sales Area and Its Competitors
Table 149. Jeil Pharmaceutical Carbapenem API Product Offered
Table 150. Jeil Pharmaceutical Carbapenem API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 151. Jeil Pharmaceutical Main Business
Table 152. Jeil Pharmaceutical Latest Developments
Table 153. Qilu Pharmaceutical Basic Information, Carbapenem API Manufacturing Base, Sales Area and Its Competitors
Table 154. Qilu Pharmaceutical Carbapenem API Product Offered
Table 155. Qilu Pharmaceutical Carbapenem API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 156. Qilu Pharmaceutical Main Business
Table 157. Qilu Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Carbapenem API
Figure 2. Carbapenem API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Carbapenem API Sales Growth Rate 2016-2026 (Ton)
Figure 7. Global Carbapenem API Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Carbapenem API Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Ertapenem API
Figure 10. Product Picture of Imipenem API
Figure 11. Product Picture of Meropenem API
Figure 12. Product Picture of Others
Figure 13. Global Carbapenem API Sales Market Share by Type in 2020
Figure 14. Global Carbapenem API Revenue Market Share by Type (2016-2021)
Figure 15. Carbapenem API Consumed in Intravenous Injection
Figure 16. Global Carbapenem API Market: Intravenous Injection (2016-2021) & (Ton)
Figure 17. Carbapenem API Consumed in Intramuscular Injection
Figure 18. Global Carbapenem API Market: Intramuscular Injection (2016-2021) & (Ton)
Figure 19. Global Carbapenem API Sales Market Share by Application (2016-2021)
Figure 20. Global Carbapenem API Revenue Market Share by Application in 2020
Figure 21. Carbapenem API Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Carbapenem API Revenue Market Share by Company in 2020
Figure 23. Global Carbapenem API Sales Market Share by Regions (2016-2021)
Figure 24. Global Carbapenem API Revenue Market Share by Region in 2020
Figure 25. Americas Carbapenem API Sales 2016-2021 (Ton)
Figure 26. Americas Carbapenem API Revenue 2016-2021 ($ Millions)
Figure 27. APAC Carbapenem API Sales 2016-2021 (Ton)
Figure 28. APAC Carbapenem API Revenue 2016-2021 ($ Millions)
Figure 29. Europe Carbapenem API Sales 2016-2021 (Ton)
Figure 30. Europe Carbapenem API Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Carbapenem API Sales 2016-2021 (Ton)
Figure 32. Middle East & Africa Carbapenem API Revenue 2016-2021 ($ Millions)
Figure 33. Americas Carbapenem API Sales Market Share by Country in 2020
Figure 34. Americas Carbapenem API Revenue Market Share by Country in 2020
Figure 35. Americas Carbapenem API Sales Market Share by Type in 2020
Figure 36. Americas Carbapenem API Sales Market Share by Application in 2020
Figure 37. United States Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Carbapenem API Sales Market Share by Region in 2020
Figure 42. APAC Carbapenem API Revenue Market Share by Regions in 2020
Figure 43. APAC Carbapenem API Sales Market Share by Type in 2020
Figure 44. APAC Carbapenem API Sales Market Share by Application in 2020
Figure 45. China Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Carbapenem API Sales Market Share by Country in 2020
Figure 52. Europe Carbapenem API Revenue Market Share by Country in 2020
Figure 53. Europe Carbapenem API Sales Market Share by Type in 2020
Figure 54. Europe Carbapenem API Sales Market Share by Application in 2020
Figure 55. Germany Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Carbapenem API Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Carbapenem API Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Carbapenem API Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Carbapenem API Sales Market Share by Application in 2020
Figure 64. Egypt Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Carbapenem API Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles


★調査レポート[世界のカルバペネムAPI市場予測 2021年-2026年] (コード：LPI21MY0916)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のカルバペネムAPI市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の心血管・脳血管API市場予測 2021年-2026年
    LPI21MY0941 / LP Information / 2021年5月 / LPインフォメーション社の「心血管・脳血管APIの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、サルタン心血管・脳血管API、スタチン心血管・脳血管API、プリ心血管・脳血管APIなど、用途別には、経口薬、注射薬などにセグメント区分してまとめました。心血管・脳血管APIのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・心血管・脳血管APIの世界市場概要（サマリー） ・心血管・脳血管APIの企業別販売量・売上 ・心血管・脳血管APIの企業別市場シェア ・心血管・脳血管APIの世界市場規模 2016年-2021年：種類別（サルタン心血管・脳血管API、スタチン心血管・脳血管API、プリ心血管・脳血管API） ・心血管・脳血管APIの世界市場規模 2016年-2021年：用途別（経口薬、注射薬） ・心血管・脳血管APIの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・心血管・脳血管APIのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Cardiovascular and Cerebrovascular API will have significant change from previous year. By the most conservative estimates of global Cardiovascular and Cerebrovascular API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2941.1 million in 2020. Over the next five years the Cardiovascular and Cerebrovascular API market will register a 2.8% CAGR in terms of revenue, the global market size will reach US$ 3282 million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular and Cerebrovascular API...
  • 世界のイオヘキソール市場予測 2021年-2026年
    LPI21MY2604 / LP Information / 2021年5月 / LPインフォメーション社の「イオヘキソールの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、0.99、0.98、その他など、用途別には、造影剤、診断剤、その他などにセグメント区分してまとめました。イオヘキソールのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・イオヘキソールの世界市場概要（サマリー） ・イオヘキソールの企業別販売量・売上 ・イオヘキソールの企業別市場シェア ・イオヘキソールの世界市場規模 2016年-2021年：種類別（0.99、0.98、その他） ・イオヘキソールの世界市場規模 2016年-2021年：用途別（造影剤、診断剤、その他） ・イオヘキソールの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・イオヘキソールのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Iohexol (CAS 66108-95-0) will have significant change from previous year. By the most conservative estimates of global Iohexol (CAS 66108-95-0) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Iohexol (CAS 66108-95-0) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Iohexol (CAS 66108-95-0) market by product type,...
  • 世界のメロペネムAPI市場予測 2021年-2026年
    LPI21MY1887 / LP Information / 2021年5月 / LPインフォメーション社の「メロペネムAPIの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、粗メロペネム、注射グレードメロペネムなど、用途別には、静脈注射、筋肉内注射などにセグメント区分してまとめました。メロペネムAPIのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・メロペネムAPIの世界市場概要（サマリー） ・メロペネムAPIの企業別販売量・売上 ・メロペネムAPIの企業別市場シェア ・メロペネムAPIの世界市場規模 2016年-2021年：種類別（粗メロペネム、注射グレードメロペネム） ・メロペネムAPIの世界市場規模 2016年-2021年：用途別（静脈注射、筋肉内注射） ・メロペネムAPIの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・メロペネムAPIのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Meropenem API will have significant change from previous year. By the most conservative estimates of global Meropenem API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in 2020. Over the next five years the Meropenem API market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Meropenem API market by product type, application, key manufacturers and...
  • 世界の注射用エルタペネム市場予測 2021年-2026年
    LPI21MY1305 / LP Information / 2021年5月 / LPインフォメーション社の「注射用エルタペネムの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、純度> 98％、純度> 99％など、用途別には、静脈注射、筋肉内注射などにセグメント区分してまとめました。注射用エルタペネムのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・注射用エルタペネムの世界市場概要（サマリー） ・注射用エルタペネムの企業別販売量・売上 ・注射用エルタペネムの企業別市場シェア ・注射用エルタペネムの世界市場規模 2016年-2021年：種類別（純度> 98％、純度> 99％）...According to this latest study, the 2021 growth of Ertapenem for Injection will have significant change from previous year. By the most conservative estimates of global Ertapenem for Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Ertapenem for Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Ertapenem for Injection market by product type,...
  • 世界のパラセタモール有効成分市場予測 2021年-2026年
    LPI21MY2144 / LP Information / 2021年5月 / LPインフォメーション社の「パラセタモール有効成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、純度（99％-99.5％）、純度（99.5％以上）、純度（99％以下）など、用途別には、頭痛＆発熱、風邪＆咳、筋肉けいれん、その他などにセグメント区分してまとめました。パラセタモール有効成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・パラセタモール有効成分の世界市場概要（サマリー） ・パラセタモール有効成分の企業別販売量・売上 ・パラセタモール有効成分の企業別市場シェア ・パラセタモール有効成分の世界市場規模 2016年-2021年：種類別（純度（99％-99.5％）、純度（99.5％以上）、純度（99％以下）） ・パラセタモール有効成分の世界市場規模 2016年-2021年：用途別（頭痛＆発熱、風邪＆咳、筋肉けいれん、その他） ・パラセタモール有効成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・パラセタモール有効成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Paracetamol Active Pharmaceutical Ingredients will have significant change from previous year. By the most conservative estimates of global Paracetamol Active Pharmaceutical Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Paracetamol Active Pharmaceutical Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Paracetamol Active Pharmaceutical Ingredients...
  • 世界の解熱鎮痛薬用有効成分市場予測 2021年-2026年
    LPI21MY0712 / LP Information / 2021年5月 / LPインフォメーション社の「解熱鎮痛薬用有効成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他など、用途別には、頭痛・発熱、風邪・咳、筋肉痙攣、その他などにセグメント区分してまとめました。解熱鎮痛薬用有効成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・解熱鎮痛薬用有効成分の世界市場概要（サマリー） ・解熱鎮痛薬用有効成分の企業別販売量・売上 ・解熱鎮痛薬用有効成分の企業別市場シェア ・解熱鎮痛薬用有効成分の世界市場規模 2016年-2021年：種類別（パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他） ・解熱鎮痛薬用有効成分の世界市場規模 2016年-2021年：用途別（頭痛・発熱、風邪・咳、筋肉痙攣、その他） ・解熱鎮痛薬用有効成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・解熱鎮痛薬用有効成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Antipyretic Analgesic Active Pharmaceutical Ingredients will have significant change from previous year. By the most conservative estimates of global Antipyretic Analgesic Active Pharmaceutical Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Antipyretic Analgesic Active Pharmaceutical Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Antipyretic...
  • 世界のR-3-THF-OL市場予測 2021年-2026年
    LPI21MY1595 / LP Information / 2021年5月 / LPインフォメーション社の「R-3-THF-OLの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、純度≥99％、純度...According to this latest study, the 2021 growth of R-3-THF-OL(CAS：86087-24-3) will have significant change from previous year. By the most conservative estimates of global R-3-THF-OL(CAS：86087-24-3) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the R-3-THF-OL(CAS：86087-24-3) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of R-3-THF-OL(CAS：86087-24-3) market by product type, application, key manufacturers and key regions and countries....
  • 世界のS-3-THF-OL市場予測 2021年-2026年
    LPI21MY1665 / LP Information / 2021年5月 / LPインフォメーション社の「S-3-THF-OLの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、純度≥99％、純度...According to this latest study, the 2021 growth of S-3-THF-OL (CAS：86087-23-2) will have significant change from previous year. By the most conservative estimates of global S-3-THF-OL (CAS：86087-23-2) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the S-3-THF-OL (CAS：86087-23-2) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of S-3-THF-OL (CAS：86087-23-2) market by product type, application, key manufacturers and...
  • 世界のスピノサド市場予測 2021年-2026年
    LPI21MY2723 / LP Information / 2021年5月 / LPインフォメーション社の「スピノサドの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、スプレー、ほこり、顆粒、錠剤、懸濁液など、用途別には、農薬、研究、工業、家庭用化合物、医薬品などにセグメント区分してまとめました。スピノサドのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・スピノサドの世界市場概要（サマリー） ・スピノサドの企業別販売量・売上 ・スピノサドの企業別市場シェア ・スピノサドの世界市場規模 2016年-2021年：種類別（スプレー、ほこり、顆粒、錠剤、懸濁液） ・スピノサドの世界市場規模 2016年-2021年：用途別（農薬、研究、工業、家庭用化合物、医薬品） ・スピノサドの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・スピノサドのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Spinosad will have significant change from previous year. By the most conservative estimates of global Spinosad market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Spinosad market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Spinosad market by product type, application, key manufacturers and key regions and countries....
  • 世界の2-ブチン酸市場予測 2021年-2026年
    LPI21MY3092 / LP Information / 2021年5月 / LPインフォメーション社の「2-ブチン酸の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、98% 純度、 99% 純度など、用途別には、有機合成、医薬品中間体、その他などにセグメント区分してまとめました。2-ブチン酸のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・2-ブチン酸の世界市場概要（サマリー） ・2-ブチン酸の企業別販売量・売上 ・2-ブチン酸の企業別市場シェア ・2-ブチン酸の世界市場規模 2016年-2021年：種類別（98% 純度、...According to this latest study, the 2021 growth of 2-butynoic Acid will have significant change from previous year. By the most conservative estimates of global 2-butynoic Acid market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the 2-butynoic Acid market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of 2-butynoic Acid market by product type, application, key manufacturers and...

    • ◆H&Iグローバルリサーチのお客様（例）◆